sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc.: Disclosure on Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 concerning its interest in Mural Oncology plc regarding the Irish Takeover Panel Act. The disclosure notes that Vanguard holds 771,731 ordinary shares, equating to 4.47% of Mural Oncology's total shares. This form is essential for adherence to Rule 8.3, addressing shares amounting to 1% or more.
The disclosure was made as of August 19, 2025. Vanguard's dealings included the sale of 16 ordinary shares at $1.80 each. There have been no significant agreements or arrangements influencing the securities beyond this disclosure, with documentation affirming the absence of any Supplemental Form 8 attached.
This filing ensures transparency and compliance with the relevant takeover rules, maintaining market integrity in corporate dealings.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.